Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.42 DKK Market Closed
Market Cap: 645.6m DKK

Relative Value

The Relative Value of one BIOPOR stock under the Base Case scenario is 0.83 DKK. Compared to the current market price of 1.42 DKK, Bioporto A/S is Overvalued by 41%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOPOR Relative Value
Base Case
0.83 DKK
Overvaluation 41%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
33
Median 3Y
19.2
Median 5Y
20.2
Industry
6.8
Forward
11.6
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-9.8
Industry
21.9
Forward
-7.4
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-9.9
Industry
19.5
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9.3
Industry
23.4
vs History
17
vs Industry
14
Median 3Y
9.5
Median 5Y
10.7
Industry
2.4
vs History
66
vs Industry
29
Median 3Y
17.3
Median 5Y
19.4
Industry
7.2
Forward
11.1
vs History
65
vs Industry
24
Median 3Y
26.8
Median 5Y
29.6
Industry
9.1
vs History
vs Industry
Median 3Y
-8.2
Median 5Y
-8.5
Industry
3.9
vs History
vs Industry
Median 3Y
-7.9
Median 5Y
-8.1
Industry
3.8
Forward
-6.8
vs History
vs Industry
Median 3Y
-8.7
Median 5Y
-9.1
Industry
4.4
vs History
vs Industry
Median 3Y
-8.7
Median 5Y
-9.1
Industry
3.5
vs History
76
vs Industry
13
Median 3Y
22.4
Median 5Y
22
Industry
4.4

Multiples Across Competitors

BIOPOR Competitors Multiples
Bioporto A/S Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Bioporto A/S
CSE:BIOPOR
610.1m DKK 17.7 -7.4 -6.6 -6.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 976 450.8 -166 237.9 -201 865.8 -199 562.3
US
Abbvie Inc
NYSE:ABBV
322.5B USD 5.6 77.8 14.9 22
US
Amgen Inc
NASDAQ:AMGN
145.9B USD 4.3 24.6 13.5 22.2
US
Gilead Sciences Inc
NASDAQ:GILD
132.7B USD 4.6 22.3 9.7 13.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.1B USD 10 -112.4 23.8 25
US
Epizyme Inc
F:EPE
94.1B EUR 2 014.2 -514 -559.7 -544.7
AU
CSL Ltd
ASX:CSL
119.4B AUD 5 27.9 17.2 21.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
64.7B USD 4.6 14.4 13 14.5
US
Seagen Inc
F:SGT
39.3B EUR 19.4 -59.5 -64.1 -57.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
37.7B USD 16.1 -140.4 -625 -313.2
P/S Multiple
Revenue Growth P/S to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average P/S: 3 179 868.4
17.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 976 450.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.3
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.6
3%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10
10%
1
US
E
Epizyme Inc
F:EPE
2 014.2
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.6
5%
0.9
US
S
Seagen Inc
F:SGT
19.4
30%
0.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.1
29%
0.6
P/E Multiple
Earnings Growth PEG
DK
Bioporto A/S
CSE:BIOPOR
Average P/E: 33.4
Negative Multiple: -7.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -166 237.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
77.8
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
24.6
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
22.3
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -112.4 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514 N/A N/A
AU
CSL Ltd
ASX:CSL
27.9
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.4
7%
2.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -140.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average EV/EBITDA: 15.3
Negative Multiple: -6.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -201 865.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
14.9
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
13.5
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.7
7%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.8
18%
1.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13
14%
0.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -625 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average EV/EBIT: 19.8
Negative Multiple: -6.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 562.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
22.2
31%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.4
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -544.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.6
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.5
13%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -313.2 N/A N/A